Shuaibing Liu
- Molecular Biology
- Pharmacology top 10%
- Cardiology and Cardiovascular Medicine
- Oncology
- Transplantation top 10%
- Co-authors
- Xin TianLeslie Z. BenetJasleen K. SodhiXiaojian ZhangLiyan MiaoLing XueHua ZhangJingjing Zhang
- Topics
- Pharmacogenetics and Drug Metabolism (11 papers)Antiplatelet Therapy and Cardiovascular Diseases (9 papers)Inflammatory mediators and NSAID effects (7 papers)
- Partner nations
- ChinaUnited StatesSingapore
In The Last Decade
Shuaibing Liu
32 papers receiving 317 citations
Peers
Comparison fields: 5 of 82
- Molecular Biology 97
- Pharmacology 70
- Cardiology and Cardiovascular Medicine 57
- Oncology 42
- Transplantation 40
Countries citing papers authored by Shuaibing Liu
This map shows the geographic impact of Shuaibing Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shuaibing Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shuaibing Liu more than expected).
Fields of papers citing papers by Shuaibing Liu
This network shows the impact of papers produced by Shuaibing Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shuaibing Liu. The network helps show where Shuaibing Liu may publish in the future.
Co-authorship network of co-authors of Shuaibing Liu
This figure shows the co-authorship network connecting the top 25 collaborators of Shuaibing Liu. A scholar is included among the top collaborators of Shuaibing Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shuaibing Liu. Shuaibing Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 0 | |
| 4 | 0 | |
| 5 | 7 | |
| 6 | 5 | |
| 7 | 4 | |
| 8 | 10 | |
| 9 | 2 | |
| 10 | 6 | |
| 11 | 11 | |
| 12 | 8 | |
| 13 | 8 | |
| 14 | 18 | |
| 15 | 9 | |
| 16 | 10 | |
| 17 | 9 | |
| 18 | 19 | |
| 19 | 36 | |
| 20 | 19 |
About Shuaibing Liu
Shuaibing Liu is a scholar working on Pharmacology, Pharmacology and Toxicology, having authored 36 papers that have together received 319 indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (11 papers), Antiplatelet Therapy and Cardiovascular Diseases (9 papers) and Inflammatory mediators and NSAID effects (7 papers). The work is most often cited by research in Transplantation (40 citations), Pharmacology (70 citations) and Internal Medicine (14 citations). Shuaibing Liu has collaborated with scholars based in China, United States and Singapore. Frequent co-authors include Xin Tian, Leslie Z. Benet, Jasleen K. Sodhi, Xiaojian Zhang, Liyan Miao, Ling Xue, Hua Zhang, Jingjing Zhang, Liyan Miao and Lichuan Wu. Their work appears in journals such as ACS Nano, Scientific Reports and Acta Biomaterialia.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.